c-MET signaling plays a critical role in tumor progression, invasion, and metastasis, and we have recently shown it to be associated with poor prognosis in locally advanced HNSCC patients treated with chemoradiation [26]. Here, MET is linked to head and neck squamous cell carcinoma.